Simultaneous Targeting of Bladder Tumor Growth, Survival, and Epithelial-to-Mesenchymal Transition with a Novel Therapeutic Combination of Acetazolamide (AZ) and Sulforaphane (SFN)-Reference-Cited by-同舟云学术

Simultaneous Targeting of Bladder Tumor Growth, Survival, and Epithelial-to-Mesenchymal Transition with a Novel Therapeutic Combination of Acetazolamide (AZ) and Sulforaphane (SFN)

Published:2015-10-10 Issue:2 Volume:11 Page:209-227
ISSN:1776-2596
Container-title:Targeted Oncology
language:en
Short-container-title:Targ Oncol

Author:

Islam S S,Mokhtari R B,Akbari P,Hatina J,Yeger H,Farhat W A

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11523-015-0386-5.pdf

Reference58 articles.

1. Ching CB, Hansel DE (2010) Expanding therapeutic target in bladder cancer: the PI3K/Akt/mTOR pathway. Lab Investig 90(10):1406–1414

2. Siegel RL, Miller MD, Jemal A (2015) Cancer statistics. CA Cancer J Clin 65:5–29

3. Chiong E, Lee IL, Dadbin A, Sabichi AL, Harris L, Urbauer D et al (2014) Effects of mTOR inhibitor everolimus (RAD001) on bladder cancer. Clin Cancer Res 17(9):2863–2878

4. Lekas A, Papathomas TG, Papatsoris AG, Deliveliotis C, Lazaris AC (2008) Novel therapeutics in metastatic bladder cancer. Expert Opin Investig Drugs 17(12):1889–1899

5. Serrano C, Morales R, Suárez C, Núñez I, Valverde C, Rodón J et al (2012) Emerging therapies for urothelial cancer. Cancer Treat Rev 38(4):311–7

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Moscatilin Reverses EMT Progression and its Resulting Enhanced Invasion and Migration by Affecting the TGF-β Signaling Pathway in Bladder Cancer;Anti-Cancer Agents in Medicinal Chemistry;2024-08

2. Phenethyl isothiocyanate inhibits the carcinogenic properties of hepatocellular carcinoma Huh7.5.1 cells by activating MAPK/PI3K-Akt/p53 signaling pathways;PeerJ;2024-06-10

3. The pharmacoepigenetic paradigm in cancer treatment;Frontiers in Pharmacology;2024-04-24

4. Harnessing Sulforaphane Potential as a Chemosensitizing Agent: A Comprehensive Review;Cancers;2024-01-05

5. Sulforaphane and bladder cancer: a potential novel antitumor compound;Frontiers in Pharmacology;2023-09-15